Table 2 of
Mimiwati, Mol Vis 2014; 20:714-723.
Table 2. Clinical characteristic of JOAG probands.
ID | Sex | Visual acuity | Age | IOP | VCDR | CCT | HRT(RNFL thickness) | Visual field | Treatment | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
OD | OS | OD | OS | OD | OS | OD | OS | OD | OS | OD | OS | ||||
II:3 | F | NPL | NPL | 38 | 35 | 10 | Nil | Nil | Nil | Nil | Nil | Nil | Severe | Severe | No |
II:7 | F | NPL | 6/12 | 25 | Nil | 12 | 0.9 | 0.9 | Nil | 510 | Nil | Borderline | Severe | Severe | Surgical |
II:11 | F | 6/15 | 6/15 | 40 | 16 | 20 | 0.9 | 0.5 | 551 | 527 | Abnormal | Abnormal | Severe | Severe | Surgical |
II:14 | M | NPL | 6/7.5 | 40 | 58 | 58 | Nil | 0.7 | 557 | 539 | Nil | Abnormal | Severe | Severe | Surgical |
III:2 | F | NPL | NPL | 42 | 42 | 42 | Nil | Nil | 539 | 480 | Nil | Nil | Severe | Severe | No |
III:3 | F | 6/6 | 6/7.5 | 40 | 56 | 56 | 0.9 | 0.9 | 468 | 469 | Borderline | Normal | Severe | Severe | Medical |
III:5* | M | 6/7.5 | 6/7.5 | 47 | 24 | 16 | 0.8 | 0.2 | 515 | 497 | Borderline | Normal | Severe | Severe | Nil |
III:6 | F | 6/6 | 6/6 | 40 | 20 | 24 | 0.5 | 0.4 | Nil | Nil | Nil | Nil | Mild | Normal | Medical |
III:7 | M | NPL | NPL | 36 | 46 | 45 | 1 | 0.9 | Nil | Nil | Abnormal | Abnormal | Severe | Severe | Nil |
III:8 | F | HM | 6/24 | 31 | 11 | 17 | 0.9 | 0.8 | Nil | Nil | Normal | Normal | Severe | Severe | Medical |
III:19 | F | NPL | 6/12 | 36 | 60 | 40 | 0.9 | 0.3 | 533 | 502 | Normal | Nil | Severe | Normal | Surgical |
III:20 | F | 6/6 | NPL | 34 | 16 | 16 | 0.9 | 0.9 | Nil | Nil | Normal | Normal | Severe | Severe | Surgical |
III:21 | M | 6/7.5 | 6/7.5 | 29 | 32 | 32 | 0.7 | 0.6 | 466 | 439 | Normal | Normal | Severe | Moderate | Both |
III:23 | M | 6/6 | 6/6 | 32 | 20 | 23 | 0.5 | 0.3 | 510 | 512 | Normal | Normal | Normal | Mild | Surgical |
III:24* | F | 6/6 | 6/6 | 37 | 49 | 33 | 0.7 | 0.5 | 517 | 509 | Normal | Abnormal | Normal | Normal | Medical |
III:25* | M | 6/6 | 6/6 | 34 | 49 | 49 | 0.8 | 0.9 | 517 | 506 | Nil | Nil | Normal | Severe | Medical |
III:27 | F | PL | 6/9 | 17 | 30 | 22 | 0.9 | 0.9 | Nil | Nil | Normal | Normal | Severe | Severe | Surgical |
III:28* | M | 6/7.5 | 6/6 | 23 | 28 | 35 | 0.4 | 0.5 | 501 | 506 | Abnormal | Abnormal | Normal | Normal | Medical |
III:36 | M | 6/18 | 6/6 | 32 | 50 | 50 | 0.9 | 0.9 | 504 | 499 | Normal | Abnormal | Severe | Moderate | Both |
III:39 | F | 6/6 | 6/6 | 24 | 16 | 14 | 0.5 | 0.7 | 510 | 513 | Nil | Nil | Normal | Normal | Medical |
III:40 | F | 6/9 | 6/6 | 25 | 20 | 19 | 0.5 | 0.3 | 487 | 488 | Normal | Normal | Normal | Normal | Medical |
III:41* | M | 6/6 | 6/6 | 30 | 50 | 54 | 0.3 | 0.3 | 563 | 560 | Normal | Normal | Normal | Normal | Medical |
III:42* | M | 6/6 | 6/6 | 25 | 29 | 37 | 0.6 | 0.7 | 557 | 556 | Normal | Normal | Normal | Normal | Medical |
III:43 | F | 6/5 | 6/5 | 16 | 24 | 22 | 0.3 | 0.3 | 519 | 529 | Nil | Nil | Normal | Normal | Medical |
III:59* | M | 6/7.5 | 6/7.5 | 22 | 27 | 25 | 0.4 | 0.3 | 557 | 565 | Abnormal | Borderline | Normal | Normal | Medical |
III:62* | M | 6/6 | 6/6 | 17 | 36 | 36 | 0.8 | 0.7 | 537 | 554 | Abnormal | Abnormal | Severe | Severe | Medical |
III:63* | M | 6/7.5 | 6/7.5 | 16 | 38 | 40 | 0.6 | 0.9 | 527 | 532 | Abnormal | Abnormal | Moderate | Severe | Medical |
IV:1 | M | NPL | NPL | 16 | 44 | 5 | 0.9 | 0.9 | 488 | 536 | Abnormal | Abnormal | Severe | Severe | No |
IV:6 | M | 6/9 | 6/7.5 | 33 | 53 | 54 | 0.9 | 0.9 | 531 | 534 | Normal | Normal | Severe | Severe | Medical |
IV:11* | F | 6/6 | 6/6 | 31 | 34 | 25 | 0.4 | 0.4 | 454 | 455 | Normal | Normal | Normal | Normal | Medical |
IV:15* | M | 6/7.5 | 6/7.5 | 18 | 26 | 26 | 0.6 | 0.4 | 465 | 466 | Normal | Normal | Mild | Moderate | Medical |
IV:48 | F | 6/12 | 6/9 | 13 | 33 | 33 | 0.4 | 0.4 | 565 | 562 | Normal | Normal | Normal | Normal | Both |